- Thursday, October 7, 2021
10:00 AM – 11:05 AM EDT
Opening Panel: Innovations Worth Keeping: Positive Practice Changes After the COVID-19 Pandemic
10:00 AM – 11:05 AM EDT
Opening Panel: Innovations Worth Keeping: Positive Practice Changes After the COVID-19 PandemicModerator: – Winship Cancer Institute of Emory University
Speaker: – Memorial Sloan Kettering Cancer Center
Speaker: – Winship Cancer Institute at Emory University
Speaker: – American Cancer Society
CE Session
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA – Winship Cancer Institute of Emory University ### 161963###Moderator###Professor and Director, Phase I Clinical Trials Section###Winship Cancer Institute of Emory University###Moderator: – Winship Cancer Institute of Emory University
@@@ Aaron Begue, MS, RN, NP-C – Memorial Sloan Kettering Cancer Center ### 1456633###Speaker###VP, Advanced Practice Providers###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
@@@ Caleb Raine, PA-C – Winship Cancer Institute at Emory University ### 1456635###Speaker###Physician Assistant###Winship Cancer Institute at Emory University###Speaker: – Winship Cancer Institute at Emory University
@@@ Robin Yabroff, PhD, MBA – American Cancer Society ### 1456631###Speaker###Scientific Vice President###American Cancer Society###Speaker: – American Cancer Society
10:00 AM – 8:15 PM EDT
Industry Encore Posters
10:00 AM – 8:15 PM EDT
Industry Encore PostersPosters
11:15 AM – 12:00 PM EDT
Clinically Relevant Drug Interactions in the Cancer Setting
11:15 AM – 12:00 PM EDT
Clinically Relevant Drug Interactions in the Cancer SettingSpeaker: – University of Florida College of Pharmacy
CE Session
David DeRemer, PharmD, BCOP, FCCP, FHOPA – University of Florida College of Pharmacy ### 863157###Speaker###Clinical Associate Professor Assistant Director, Experimental Therapeutics Incubator###University of Florida College of Pharmacy###Speaker: – University of Florida College of Pharmacy
12:15 PM – 1:00 PM EDT
Considerations for the Treatment of Patients With Lung Cancer: Resectable NSCLC and Unresectable Stage III NSCLC - AstraZeneca
12:15 PM – 1:00 PM EDT
Considerations for the Treatment of Patients With Lung Cancer: Resectable NSCLC and Unresectable Stage III NSCLC - AstraZenecaProduct Theater
1:00 PM – 1:45 PM EDT
Moderated Clinical Posters
1:00 PM – 1:45 PM EDT
Moderated Clinical PostersNetworking
Posters
1:45 PM – 2:15 PM EDT
Micro-Community Meet Ups
1:45 PM – 2:15 PM EDT
Micro-Community Meet UpsNetworking
2:15 PM – 3:00 PM EDT
Immunotherapies for the Treatment of Triple-Negative Breast Cancer
2:15 PM – 3:00 PM EDT
Immunotherapies for the Treatment of Triple-Negative Breast CancerSpeaker: – Dana Farber Cancer Institute
Speaker: – Dana Farber Cancer Institute
CE Session
Sara M. Tolaney, MD, MPH – Dana Farber Cancer Institute ### 1398059###Speaker###Associate Professor of Medicine###Dana Farber Cancer Institute###Speaker: – Dana Farber Cancer Institute
@@@ Lindsay Shaw, ANP-BC, AOCNP – Dana Farber Cancer Institute ### 1398060###Speaker###Nurse Practitioner###Dana Farber Cancer Institute###Speaker: – Dana Farber Cancer Institute
3:15 PM – 4:00 PM EDT
Managing Immune-related Adverse Events with Checkpoint Inhibitors - GSK
3:15 PM – 4:00 PM EDT
Managing Immune-related Adverse Events with Checkpoint Inhibitors - GSKProduct Theater
4:15 PM – 4:45 PM EDT
Updates in the Diffuse Large B-Cell Lymphoma Treatment Landscape
4:15 PM – 4:45 PM EDT
Updates in the Diffuse Large B-Cell Lymphoma Treatment LandscapeSpeaker: – Memorial Sloan Kettering Cancer Center
Speaker: – Memorial Sloan Kettering Cancer Center
CE Session
Ashley Ames, MSN, RN, FNP-BC, OCN – Memorial Sloan Kettering Cancer Center ### 1394199###Speaker######Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
@@@ Diane Lee, MSN, AGPCNP-BC – Memorial Sloan Kettering Cancer Center ### 1394200###Speaker###Nurse Practitioner###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
5:15 PM – 6:00 PM EDT
Product Theater
5:15 PM – 6:00 PM EDT
Introducing an Oral Treatment Option for Advanced Prostate Cancer - Myovant Sciences GmbH and Pfizer Inc.Product Theater
6:15 PM – 7:15 PM EDT
Opening Panel: Innovations Worth Keeping: Positive Practice Changes After the COVID-19 Pandemic
6:15 PM – 7:15 PM EDT
Opening Panel: Innovations Worth Keeping: Positive Practice Changes After the COVID-19 PandemicModerator: – Winship Cancer Institute of Emory University
Speaker: – Memorial Sloan Kettering Cancer Center
Speaker: – Winship Cancer Institute at Emory University
Speaker: – American Cancer Society
CE Session
Repeat Session
R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA – Winship Cancer Institute of Emory University ### 161963###Moderator###Professor and Director, Phase I Clinical Trials Section###Winship Cancer Institute of Emory University###Moderator: – Winship Cancer Institute of Emory University
@@@ Aaron Begue, MS, RN, NP-C – Memorial Sloan Kettering Cancer Center ### 1456633###Speaker###VP, Advanced Practice Providers###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
@@@ Caleb Raine, PA-C – Winship Cancer Institute at Emory University ### 1456635###Speaker###Physician Assistant###Winship Cancer Institute at Emory University###Speaker: – Winship Cancer Institute at Emory University
@@@ Robin Yabroff, PhD, MBA – American Cancer Society ### 1456631###Speaker###Scientific Vice President###American Cancer Society###Speaker: – American Cancer Society
7:30 PM – 8:15 PM EDT
Clinically Relevant Drug Interactions in the Cancer Setting
7:30 PM – 8:15 PM EDT
Clinically Relevant Drug Interactions in the Cancer SettingSpeaker: – University of Florida College of Pharmacy
CE Session
Repeat Session
David DeRemer, PharmD, BCOP, FCCP, FHOPA – University of Florida College of Pharmacy ### 863157###Speaker###Clinical Associate Professor Assistant Director, Experimental Therapeutics Incubator###University of Florida College of Pharmacy###Speaker: – University of Florida College of Pharmacy
- Friday, October 8, 2021
8:30 AM – 9:45 AM EDT
Independent Satellite Symposium: Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver Mutations
8:30 AM – 9:45 AM EDT
Independent Satellite Symposium: Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver Mutations Speaker: – Yale Comprehensive Cancer Center
West Haven, Connecticut
Speaker: – Massachusetts General Hospital
Harvard Medicine School
Boston, Massachusetts
Separate Registration
CE Session
1.25 credits/contact hours
Marianne Davies, DNP, ACNP, AOCNP, FAAN – Yale Comprehensive Cancer Center
West Haven, Connecticut ### 1458792###Speaker###Associate Professor, Yale School of Nursing
Oncology Nurse Practitioner, Thoracic & Solid Tumor###Yale Comprehensive Cancer Center
West Haven, Connecticut###Speaker: – Yale Comprehensive Cancer Center
West Haven, Connecticut
@@@ Justin Gainor, MD – Massachusetts General Hospital
Harvard Medicine School
Boston, Massachusetts ### 1458793###Speaker###Director, Center for Thoracic Cancers
Director, Targeted Immunotherapy
Associate Professor of Medicine###Massachusetts General Hospital
Harvard Medicine School
Boston, Massachusetts###Speaker: – Massachusetts General Hospital
Harvard Medicine School
Boston, Massachusetts
10:00 AM – 10:45 AM EDT
Cardio-Oncology Considerations in Oncologic Treatment Decisions
10:00 AM – 10:45 AM EDT
Cardio-Oncology Considerations in Oncologic Treatment DecisionsSpeaker: – MD Anderson Cancer Center
CE Session
Anecita P. Fadol, PhD, RN, FNP, FAANP, FAAN – MD Anderson Cancer Center ### 574772###Speaker###Associate Professor###MD Anderson Cancer Center###Speaker: – MD Anderson Cancer Center
10:00 AM – 6:30 PM EDT
Industry Encore Posters
10:00 AM – 6:30 PM EDT
Industry Encore PostersPosters
11:00 AM – 11:45 AM EDT
An Overview of Reblozyl (luspatercept-aamt) - Bristol Myers Squibb
11:00 AM – 11:45 AM EDT
An Overview of Reblozyl (luspatercept-aamt) - Bristol Myers SquibbProduct Theater
12:00 PM – 1:00 PM EDT
The Mary Pazdur Award Presentation Followed by the Keynote Interview: Pull Up a Seat: Engaging Patients as Empowered Partners in Health Equity Transformation
12:00 PM – 1:00 PM EDT
The Mary Pazdur Award Presentation Followed by the Keynote Interview: Pull Up a Seat: Engaging Patients as Empowered Partners in Health Equity TransformationSpeaker: – Tigerlily Foundation
Speaker: – Memorial Sloan Kettering Cancer Center
CE Session
Maimah Karmo – Tigerlily Foundation ### 1402680###Speaker###Founder/CEO###Tigerlily Foundation###Speaker: – Tigerlily Foundation
@@@ Amy E. Pierre, MSN, ANP-BC – Memorial Sloan Kettering Cancer Center ### 885897###Speaker###Nurse Practitioner###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
1:15 PM – 1:45 PM EDT
Mental Health in the Oncology Setting: General Considerations and Treatment Tips
1:15 PM – 1:45 PM EDT
Mental Health in the Oncology Setting: General Considerations and Treatment TipsSpeaker: – USC School of Pharmacy
CE Session
Lisa Goldstone, MS, PharmD, BCPS, BCPP – USC School of Pharmacy ### 1402518###Speaker###Associate Professor of Clinical Pharmacy###USC School of Pharmacy###Speaker: – USC School of Pharmacy
2:00 PM – 2:45 PM EDT
Product Theater
2:00 PM – 2:45 PM EDT
A Treatment Option for Patients with Advanced or Metastatic Gastric Cancer, Gastroesophageal Junction Cancer and Esophageal Adenocarcinoma - Bristol Myers Squibb Product Theater
3:00 PM – 3:30 PM EDT
Thriving, Not Just Surviving: Recognizing Burnout and Simple Tips to Start Feeling Better
3:00 PM – 3:30 PM EDT
Thriving, Not Just Surviving: Recognizing Burnout and Simple Tips to Start Feeling BetterSpeaker: – Duke University Health System
CE Session
Margaret Leddy, PA-C – Duke University Health System ### 1394207###Speaker###Physician Assistant###Duke University Health System###Speaker: – Duke University Health System
3:45 PM – 4:30 PM EDT
Product Theater
3:45 PM – 4:30 PM EDT
A Review of Evidence-Based Data for an Antibody-Drug Conjugate for locally advanced or mUC - Seagen Inc.Product Theater
4:45 PM – 5:30 PM EDT
Cardio-Oncology Considerations in Oncologic Treatment Decisions
4:45 PM – 5:30 PM EDT
Cardio-Oncology Considerations in Oncologic Treatment DecisionsSpeaker: – MD Anderson Cancer Center
CE Session
Repeat Session
Anecita P. Fadol, PhD, RN, FNP, FAANP, FAAN – MD Anderson Cancer Center ### 574772###Speaker###Associate Professor###MD Anderson Cancer Center###Speaker: – MD Anderson Cancer Center
5:45 PM – 6:30 PM EDT
Keynote Interview: Pull Up a Seat: Engaging Patients as Empowered Partners in Health Equity Transformation
5:45 PM – 6:30 PM EDT
Keynote Interview: Pull Up a Seat: Engaging Patients as Empowered Partners in Health Equity TransformationSpeaker: – Tigerlily Foundation
Speaker: – Memorial Sloan Kettering Cancer Center
CE Session
Repeat Session
Maimah Karmo – Tigerlily Foundation ### 1402680###Speaker###Founder/CEO###Tigerlily Foundation###Speaker: – Tigerlily Foundation
@@@ Amy E. Pierre, MSN, ANP-BC – Memorial Sloan Kettering Cancer Center ### 885897###Speaker###Nurse Practitioner###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
7:00 PM – 8:15 PM EDT
Independent Satellite Symposium: Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver
7:00 PM – 8:15 PM EDT
Independent Satellite Symposium: Approaches for Optimal Molecular Testing, Treatment, and Management of NSCLC and Accompanying Driver MutationsSpeaker: – Yale Comprehensive Cancer Center
West Haven, Connecticut
Speaker: – Massachusetts General Hospital
Harvard Medicine School
Boston, Massachusetts
Separate Registration
CE Session
Repeat Session
1.25 credits/contact hours
Marianne Davies, DNP, ACNP, AOCNP, FAAN – Yale Comprehensive Cancer Center
West Haven, Connecticut ### 1458792###Speaker###Associate Professor, Yale School of Nursing
Oncology Nurse Practitioner, Thoracic & Solid Tumor###Yale Comprehensive Cancer Center
West Haven, Connecticut###Speaker: – Yale Comprehensive Cancer Center
West Haven, Connecticut
@@@ Justin Gainor, MD – Massachusetts General Hospital
Harvard Medicine School
Boston, Massachusetts ### 1458793###Speaker###Director, Center for Thoracic Cancers
Director, Targeted Immunotherapy
Associate Professor of Medicine###Massachusetts General Hospital
Harvard Medicine School
Boston, Massachusetts###Speaker: – Massachusetts General Hospital
Harvard Medicine School
Boston, Massachusetts
- Saturday, October 9, 2021
10:00 AM – 11:00 AM EDT
New Drug Updates: Hematologic Malignancies
10:00 AM – 11:00 AM EDT
New Drug Updates: Hematologic MalignanciesSpeaker: – M Health Fairview and Mayo Clinic College of Medicine
CE Session
Kirollos S. Hanna, PharmD, BCPS, BCOP – M Health Fairview and Mayo Clinic College of Medicine ### 1061803###Speaker###Oncology Pharmacy Manager and Assistant Professor of Pharmacy###M Health Fairview and Mayo Clinic College of Medicine###Speaker: – M Health Fairview and Mayo Clinic College of Medicine
10:00 AM – 8:45 PM EDT
Industry Encore Posters
10:00 AM – 8:45 PM EDT
Industry Encore PostersPosters
11:15 AM – 12:00 PM EDT
Product Theater
11:15 AM – 12:00 PM EDT
POLIVY+BR: Advance the Possibilities in R/R DLBCL, NOS, After at Least 2 Prior Therapies - Genentech Product Theater
12:15 PM – 1:00 PM EDT
A Call to Action: The Role of the Oncology AP in Equitable Cancer Care
12:15 PM – 1:00 PM EDT
A Call to Action: The Role of the Oncology AP in Equitable Cancer CareModerator: – Harborside
Panelist: – University of Washington Medical Center
Panelist: – Cleveland Clinic
Panelist: – University of Alabama at Birmingham
CE Session
Brianna Hoffner, MSN, ANP-BC, AOCNP® – Harborside ### 172943###Moderator###Director of Clinical Outreach and Development###Harborside###Moderator: – Harborside
@@@ Josh Epworth, ARNP – University of Washington Medical Center ### 764298###Panelist###Nurse Practitioner###University of Washington Medical Center###Panelist: – University of Washington Medical Center
@@@ Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN – Cleveland Clinic ### 186949###Panelist###Nurse Practititioner###Cleveland Clinic###Panelist: – Cleveland Clinic
@@@ Soumya J. Niranjan, BPharm, MS, PhD – University of Alabama at Birmingham ### 1394198###Panelist###Assistant Professor###University of Alabama at Birmingham###Panelist: – University of Alabama at Birmingham
1:00 PM – 1:45 PM EDT
Moderated Clinical Posters
1:00 PM – 1:45 PM EDT
Moderated Clinical PostersNetworking
Posters
1:30 PM – 2:30 PM EDT
Conversation Circles: Building a Resume/CV that Rises to the TOP
1:30 PM – 2:30 PM EDT
Conversation Circles: Building a Resume/CV that Rises to the TOPInteractive Breakout
Networking
Deborah Rust ### 1418862###Facilitator#########Facilitator:
1:30 PM – 2:30 PM EDT
Conversation Circles: Putting Equitable Cancer Care into Action
1:30 PM – 2:30 PM EDT
Conversation Circles: Putting Equitable Cancer Care into ActionFacilitator: – Cleveland Clinic
Facilitator: – University of Alabama at Birmingham
Interactive Breakout
Networking
Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN – Cleveland Clinic ### 186949###Facilitator###Nurse Practititioner###Cleveland Clinic###Facilitator: – Cleveland Clinic
@@@ Soumya J. Niranjan, BPharm, MS, PhD – University of Alabama at Birmingham ### 1394198###Facilitator###Assistant Professor###University of Alabama at Birmingham###Facilitator: – University of Alabama at Birmingham
2:45 PM – 3:30 PM EDT
Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to Know
2:45 PM – 3:30 PM EDT
Direct Oral Anticoagulants and Cancer Thrombosis: What APs Need to KnowSpeaker: – Cleveland Clinic
CE Session
Mailey Wilks, DNP, APRN, NP-C – Cleveland Clinic ### 1394205###Speaker###APRN/PA Manager###Cleveland Clinic###Speaker: – Cleveland Clinic
3:45 PM – 4:30 PM EDT
BLENREP REMS: Real World Implementation and Best Practices - GSK
3:45 PM – 4:30 PM EDT
BLENREP REMS: Real World Implementation and Best Practices - GSKProduct Theater
4:45 PM – 5:30 PM EDT
Multidisciplinary Management of Pancreatic Cancer
4:45 PM – 5:30 PM EDT
Multidisciplinary Management of Pancreatic CancerSpeaker: – University of California, San Francisco
Speaker: – University of California, San Francisco
CE Session
Pelin Cinar, MD, MS – University of California, San Francisco ### 1416179###Speaker###Associate Clinical Professor ###University of California, San Francisco###Speaker: – University of California, San Francisco
@@@ Patricia Zendejas, MSN, ANP-C, AOCNP – University of California, San Francisco ### 1416180###Speaker###Nurse Practitioner ###University of California, San Francisco###Speaker: – University of California, San Francisco
5:45 PM – 6:30 PM EDT
Clinical Cases in Polycythemia Vera: When to Intervene With Jakafi® (ruxolitinib) | Focus on Adults With Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea - Incyte Corporation
5:45 PM – 6:30 PM EDT
Clinical Cases in Polycythemia Vera: When to Intervene With Jakafi® (ruxolitinib) | Focus on Adults With Polycythemia Vera Who Have an Inadequate Response to Hydroxyurea - Incyte CorporationProduct Theater
6:45 PM – 7:45 PM EDT
New Drug Updates: Hematologic Malignancies
6:45 PM – 7:45 PM EDT
New Drug Updates: Hematologic MalignanciesSpeaker: – M Health Fairview and Mayo Clinic College of Medicine
CE Session
Repeat Session
Kirollos S. Hanna, PharmD, BCPS, BCOP – M Health Fairview and Mayo Clinic College of Medicine ### 1061803###Speaker###Oncology Pharmacy Manager and Assistant Professor of Pharmacy###M Health Fairview and Mayo Clinic College of Medicine###Speaker: – M Health Fairview and Mayo Clinic College of Medicine
8:00 PM – 8:45 PM EDT
A Call to Action: The Role of the Oncology AP in Equitable Cancer Care
8:00 PM – 8:45 PM EDT
A Call to Action: The Role of the Oncology AP in Equitable Cancer CareModerator: – Harborside
Panelist: – University of Washington Medical Center
Panelist: – Cleveland Clinic
Panelist: – University of Alabama at Birmingham
CE Session
Repeat Session
Brianna Hoffner, MSN, ANP-BC, AOCNP® – Harborside ### 172943###Moderator###Director of Clinical Outreach and Development###Harborside###Moderator: – Harborside
@@@ Josh Epworth, ARNP – University of Washington Medical Center ### 764298###Panelist###Nurse Practitioner###University of Washington Medical Center###Panelist: – University of Washington Medical Center
@@@ Beth Faiman, PhD, MSN, APRN-BC, AOCN, FAAN – Cleveland Clinic ### 186949###Panelist###Nurse Practititioner###Cleveland Clinic###Panelist: – Cleveland Clinic
@@@ Soumya J. Niranjan, BPharm, MS, PhD – University of Alabama at Birmingham ### 1394198###Panelist###Assistant Professor###University of Alabama at Birmingham###Panelist: – University of Alabama at Birmingham
- Sunday, October 10, 2021
8:30 AM – 9:45 AM EDT
Independent Satellite Symposium: CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy
8:30 AM – 9:45 AM EDT
Independent Satellite Symposium: CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor TherapySpeaker: – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida
Speaker: – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida
Separate Registration
CE Session
1.25 credits/contact hours
Lisa Nodzon, PhD, ARNP, AOCNP – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida ### 1458794###Speaker###Advanced Registered Nurse Practitioner###Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida###Speaker: – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida
@@@ Javier Pinilla Ibarz, MD, PhD – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida ### 1458795###Speaker###Senior Member, Head of the Lymphoma Section
Director of Immunotherapy###Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida###Speaker: – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida
10:00 AM – 10:45 AM EDT
Biomarker Jeopardy
10:00 AM – 10:45 AM EDT
Biomarker JeopardySpeaker: – The University of Arizona Cancer Center
Speaker: – HonorHealth - Virginia G. Piper Cancer Care Network
Speaker: – University of Texas MD Anderson Cancer Center
CE Session
Sandra E. Kurtin, PhD, ANP-C, AOCN® – The University of Arizona Cancer Center ### 885849###Speaker###Nurse Practitioner, Clinical Assistant Professor of Medicine###The University of Arizona Cancer Center###Speaker: – The University of Arizona Cancer Center
@@@ Alyssa Henglefelt, PharmD, BCOP – HonorHealth - Virginia G. Piper Cancer Care Network ### 1095222###Speaker###Clinical Pharmacy Specialist - Ambulatory Oncology###HonorHealth - Virginia G. Piper Cancer Care Network###Speaker: – HonorHealth - Virginia G. Piper Cancer Care Network
@@@ Haleigh Mistry, MS, PA-C – University of Texas MD Anderson Cancer Center ### 1394206###Speaker###Physician Assistant###University of Texas MD Anderson Cancer Center###Speaker: – University of Texas MD Anderson Cancer Center
10:00 AM – 6:15 PM EDT
Industry Encore Posters
10:00 AM – 6:15 PM EDT
Industry Encore PostersPosters
11:00 AM – 11:45 AM EDT
Clinical Trial Evidence for a CDK4/6 Inhibitor Combination Therapy Complemented by an Evaluation of Real-World Effectiveness - Pfizer Oncology
11:00 AM – 11:45 AM EDT
Clinical Trial Evidence for a CDK4/6 Inhibitor Combination Therapy Complemented by an Evaluation of Real-World Effectiveness - Pfizer OncologyProduct Theater
12:00 PM – 12:45 PM EDT
Updates in the Management of Renal Cell Carcinoma
12:00 PM – 12:45 PM EDT
Updates in the Management of Renal Cell CarcinomaSpeaker: – M Health Fairview and Mayo Clinic College of Medicine
Speaker: – The University of Texas MD Anderson Cancer Center
CE Session
Kirollos S. Hanna, PharmD, BCPS, BCOP – M Health Fairview and Mayo Clinic College of Medicine ### 1061803###Speaker###Oncology Pharmacy Manager and Assistant Professor of Pharmacy###M Health Fairview and Mayo Clinic College of Medicine###Speaker: – M Health Fairview and Mayo Clinic College of Medicine
@@@ Zita Lim, PA-C – The University of Texas MD Anderson Cancer Center ### 420439###Speaker###Physician Assistant###The University of Texas MD Anderson Cancer Center###Speaker: – The University of Texas MD Anderson Cancer Center
1:00 PM – 1:30 PM EDT
Updates in Cholangiocarcinoma
1:00 PM – 1:30 PM EDT
Updates in CholangiocarcinomaSpeaker: – Memorial Sloan Kettering Cancer Center
CE Session
Kristen O'Hagan, ANP – Memorial Sloan Kettering Cancer Center ### 1072250###Speaker###Nurse Practitioner###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
1:45 PM – 2:30 PM EDT
Product Theater
1:45 PM – 2:30 PM EDT
Advances in targeted therapy for AML: Efficacy and Practical Management of BCL-2 inhibitors - AbbVie Medical AffairsProduct Theater
2:45 PM – 3:15 PM EDT
The 4 T's of ITP: Tailoring Therapies to Treat Thrombocytopenia
2:45 PM – 3:15 PM EDT
The 4 T's of ITP: Tailoring Therapies to Treat ThrombocytopeniaSpeaker: – Boston Medical Center
CE Session
David M. Hughes, PharmD, BCOP – Boston Medical Center ### 1417495###Speaker###Clinical Pharmacy Manager###Boston Medical Center###Speaker: – Boston Medical Center
3:30 PM – 4:15 PM EDT
Clinical Management of Patients with CABOMETYX® (cabozantinib) + OPDIVO ® (nivolumab) - Exelixis
3:30 PM – 4:15 PM EDT
Clinical Management of Patients with CABOMETYX® (cabozantinib) + OPDIVO® (nivolumab) - ExelixisProduct Theater
4:30 PM – 5:15 PM EDT
Biomarker Jeopardy
4:30 PM – 5:15 PM EDT
Biomarker JeopardySpeaker: – The University of Arizona Cancer Center
Speaker: – University of Texas MD Anderson Cancer Center
Speaker: – HonorHealth - Virginia G. Piper Cancer Care Network
CE Session
Repeat Session
Sandra E. Kurtin, PhD, ANP-C, AOCN® – The University of Arizona Cancer Center ### 885849###Speaker###Nurse Practitioner, Clinical Assistant Professor of Medicine###The University of Arizona Cancer Center###Speaker: – The University of Arizona Cancer Center
@@@ Haleigh Mistry, MS, PA-C – University of Texas MD Anderson Cancer Center ### 1394206###Speaker###Physician Assistant###University of Texas MD Anderson Cancer Center###Speaker: – University of Texas MD Anderson Cancer Center
@@@ Alyssa Henglefelt, PharmD, BCOP – HonorHealth - Virginia G. Piper Cancer Care Network ### 1095222###Speaker###Clinical Pharmacy Specialist - Ambulatory Oncology###HonorHealth - Virginia G. Piper Cancer Care Network###Speaker: – HonorHealth - Virginia G. Piper Cancer Care Network
5:30 PM – 6:15 PM EDT
Updates in the Management of Renal Cell Carcinoma
5:30 PM – 6:15 PM EDT
Updates in the Management of Renal Cell CarcinomaSpeaker: – M Health Fairview and Mayo Clinic College of Medicine
Speaker: – The University of Texas MD Anderson Cancer Center
CE Session
Repeat Session
Kirollos S. Hanna, PharmD, BCPS, BCOP – M Health Fairview and Mayo Clinic College of Medicine ### 1061803###Speaker###Oncology Pharmacy Manager and Assistant Professor of Pharmacy###M Health Fairview and Mayo Clinic College of Medicine###Speaker: – M Health Fairview and Mayo Clinic College of Medicine
@@@ Zita Lim, PA-C – The University of Texas MD Anderson Cancer Center ### 420439###Speaker###Physician Assistant###The University of Texas MD Anderson Cancer Center###Speaker: – The University of Texas MD Anderson Cancer Center
6:30 PM – 7:45 PM EDT
Independent Satellite Symposium: CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor Therapy
6:30 PM – 7:45 PM EDT
Independent Satellite Symposium: CLL/SLL: Managing Adverse Events Associated with BTK Inhibitor TherapySpeaker: – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida
Speaker: – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida
Separate Registration
CE Session
Repeat Session
1.25 credits/contact hours
Lisa Nodzon, PhD, ARNP, AOCNP – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida ### 1458794###Speaker###Advanced Registered Nurse Practitioner###Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida###Speaker: – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida
@@@ Javier Pinilla Ibarz, MD, PhD – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida ### 1458795###Speaker###Senior Member, Head of the Lymphoma Section
Director of Immunotherapy###Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida###Speaker: – Malignant Hematology Department
Moffitt Cancer Center
Tampa, Florida
- Wednesday, October 13, 2021
10:30 AM – 11:45 AM EDT
Independent Satellite Symposium: Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted Therapies
10:30 AM – 11:45 AM EDT
Independent Satellite Symposium: Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted TherapiesSpeaker: – Fred Hutchinson Cancer Research Center
Seattle, Washington
Speaker: – Physician Assistant
University of Washington Medicine
Seattle, Washington
Separate Registration
CE Session
1.25 credits/contact hours
Petros Grivas, MD, PhD – Fred Hutchinson Cancer Research Center
Seattle, Washington ### 1458796###Speaker###Physician
Seattle Cancer Care Alliance
Associate Professor, Division of Medical Oncology
University of Washington School of Medicine
Clinical Director, Genitourinary Cancers Program
University of Washington Medicine
Associate Professor, Clinical Research Division###Fred Hutchinson Cancer Research Center
Seattle, Washington###Speaker: – Fred Hutchinson Cancer Research Center
Seattle, Washington
@@@ Nerina T. McDonald, PA-C – Physician Assistant
University of Washington Medicine
Seattle, Washington ### 1472246###Speaker###Physician Assistant
Seattle Cancer Care Alliance###Physician Assistant
University of Washington Medicine
Seattle, Washington###Speaker: – Physician Assistant
University of Washington Medicine
Seattle, Washington
12:00 PM – 12:30 PM EDT
APSHO Annual Member Meeting (Open to Members Only)
12:00 PM – 12:30 PM EDT
APSHO Annual Member Meeting (Open to Members Only)
12:30 PM – 4:30 PM EDT
Braindates
5:00 PM – 6:15 PM EDT
Independent Satellite Symposium: Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted Therapies
5:00 PM – 6:15 PM EDT
Independent Satellite Symposium: Navigating the Expanding Treatment Landscape in Metastatic Urothelial Cancer: Novel Targeted TherapiesSpeaker: – Fred Hutchinson Cancer Research Center
Seattle, Washington
Speaker: – Physician Assistant
University of Washington Medicine
Seattle, Washington
Separate Registration
CE Session
Repeat Session
1.25 credits/contact hours
Petros Grivas, MD, PhD – Fred Hutchinson Cancer Research Center
Seattle, Washington ### 1458796###Speaker###Physician
Seattle Cancer Care Alliance
Associate Professor, Division of Medical Oncology
University of Washington School of Medicine
Clinical Director, Genitourinary Cancers Program
University of Washington Medicine
Associate Professor, Clinical Research Division###Fred Hutchinson Cancer Research Center
Seattle, Washington###Speaker: – Fred Hutchinson Cancer Research Center
Seattle, Washington
@@@ Nerina T. McDonald, PA-C – Physician Assistant
University of Washington Medicine
Seattle, Washington ### 1472246###Speaker###Physician Assistant
Seattle Cancer Care Alliance###Physician Assistant
University of Washington Medicine
Seattle, Washington###Speaker: – Physician Assistant
University of Washington Medicine
Seattle, Washington
- Thursday, October 14, 2021
10:00 AM – 11:15 AM EDT
New Drug Updates: Solid Tumors
10:00 AM – 11:15 AM EDT
New Drug Updates: Solid TumorsSpeaker: – University of Pennsylvania
CE Session
Christine Cambareri, PharmD, BCPS, BCOP, CSP – University of Pennsylvania ### 1398035###Speaker###Outpatient Clinical Oncology Pharmacy Specialist###University of Pennsylvania###Speaker: – University of Pennsylvania
10:00 AM – 7:30 PM EDT
Industry Encore Posters
10:00 AM – 7:30 PM EDT
Industry Encore PostersPosters
11:15 AM – 12:00 PM EDT
Plan for Tomorrow Today, Managing patients with KRAS G12C-mutated NSCLC - Amgen Oncology
11:15 AM – 12:00 PM EDT
Plan for Tomorrow Today, Managing patients with KRAS G12C-mutated NSCLC - Amgen OncologyProduct Theater
12:15 PM – 1:00 PM EDT
Herbal Medicine and Supplements: Friend or Foe?
12:15 PM – 1:00 PM EDT
Herbal Medicine and Supplements: Friend or Foe?Speaker: – Billings Clinic
CE Session
Roberta V. Bourgon, N.D. – Billings Clinic ### 1418473###Speaker###Naturopathic Physician###Billings Clinic###Speaker: – Billings Clinic
12:45 PM – 1:15 PM EDT
Micro-Community Meet Ups
12:45 PM – 1:15 PM EDT
Micro-Community Meet UpsNetworking
12:45 PM – 1:30 PM EDT
Moderated Clinical Posters
12:45 PM – 1:30 PM EDT
Moderated Clinical PostersNetworking
Posters
1:30 PM – 2:15 PM EDT
New Frontiers: The Role of CAR T-Cell Therapy in Multiple Myeloma
1:30 PM – 2:15 PM EDT
New Frontiers: The Role of CAR T-Cell Therapy in Multiple MyelomaSpeaker: – Mayo Clinic
Speaker: – Mayo Clinic
CE Session
Alli McClanahan, APRN, CNP – Mayo Clinic ### 1398776###Speaker###Division of Hematology###Mayo Clinic###Speaker: – Mayo Clinic
@@@ Megan Spychalla, PA-C – Mayo Clinic ### 1398777###Speaker###Division of Hematology###Mayo Clinic###Speaker: – Mayo Clinic
2:30 PM – 3:15 PM EDT
PEMAZYRE® (pemigatinib): The First FDA-Approved Treatment for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma (CCA) with an FGFR2 Fusion or Rearrangement - Incyte Corporation
2:30 PM – 3:15 PM EDT
PEMAZYRE® (pemigatinib): The First FDA-Approved Treatment for Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma (CCA) with an FGFR2 Fusion or Rearrangement - Incyte Corporation Product Theater
3:30 PM – 4:15 PM EDT
Survivorship Care Challenges: Navigating Changing Concerns
3:30 PM – 4:15 PM EDT
Survivorship Care Challenges: Navigating Changing ConcernsSpeaker: – Thomas Jefferson University College of Nursing
CE Session
Carrie Stricker, PhD, RN, ANP-BC – Thomas Jefferson University College of Nursing ### 187564###Speaker###Associate Professor of Nursing; Program Director, Transformative Systems Leadership###Thomas Jefferson University College of Nursing###Speaker: – Thomas Jefferson University College of Nursing
4:30 PM – 5:15 PM EDT
AML Patient Cases and Supporting Data - Bristol Myers Squibb
4:30 PM – 5:15 PM EDT
AML Patient Cases and Supporting Data - Bristol Myers SquibbProduct Theater
5:30 PM – 6:45 PM EDT
New Drug Updates: Solid Tumors
5:30 PM – 6:45 PM EDT
New Drug Updates: Solid TumorsSpeaker: – University of Pennsylvania
CE Session
Repeat Session
Christine Cambareri, PharmD, BCPS, BCOP, CSP – University of Pennsylvania ### 1398035###Speaker###Outpatient Clinical Oncology Pharmacy Specialist###University of Pennsylvania###Speaker: – University of Pennsylvania
6:45 PM – 7:30 PM EDT
Herbal Medicine and Supplements: Friend or Foe?
6:45 PM – 7:30 PM EDT
Herbal Medicine and Supplements: Friend or Foe?Speaker: – Billings Clinic
CE Session
Repeat Session
Roberta V. Bourgon, N.D. – Billings Clinic ### 1418473###Speaker###Naturopathic Physician###Billings Clinic###Speaker: – Billings Clinic
7:30 PM – 8:45 PM EDT
Five Eyes: A Virtual Game Event
7:30 PM – 8:45 PM EDT
Five Eyes: A Virtual Game EventPre-Registration Required
Networking
- Friday, October 15, 2021
8:30 AM – 9:45 AM EDT
Independent Satellite Symposium: Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen Therapy
8:30 AM – 9:45 AM EDT
Independent Satellite Symposium: Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen TherapySpeaker: – Robert H Lurie Comprehensive Cancer Center
Northwestern Medicine
Chicago, Illinois
Speaker: – Dana-Farber Cancer Institute
Boston, Massachusetts
Separate Registration
CE Session
1.25 credits/contact hours
Brenda Martone, MSN, ANP-BC, AOCNP – Robert H Lurie Comprehensive Cancer Center
Northwestern Medicine
Chicago, Illinois ### 1458797###Speaker###Nurse Practitioner###Robert H Lurie Comprehensive Cancer Center
Northwestern Medicine
Chicago, Illinois###Speaker: – Robert H Lurie Comprehensive Cancer Center
Northwestern Medicine
Chicago, Illinois
@@@ Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute
Boston, Massachusetts ### 1458798###Speaker###Faculty in Medicine
Harvard Medical School
Genitourinary Medical Oncologist
Medical Director, Survivorship Program###Dana-Farber Cancer Institute
Boston, Massachusetts###Speaker: – Dana-Farber Cancer Institute
Boston, Massachusetts
10:00 AM – 11:00 AM EDT
Multidisciplinary Management of Resectable Early-Stage Non-Small Cell Lung Cancer
10:00 AM – 11:00 AM EDT
Multidisciplinary Management of Resectable Early-Stage Non-Small Cell Lung CancerSpeaker: – UW Medicine
Speaker: – UW Medicine
Speaker: – University of Washington/ Seattle Cancer Care Alliance
CE Session
Kristin DeGroot, PA-C – UW Medicine ### 1417845###Speaker###Physician Assistant/Teaching Associate###UW Medicine###Speaker: – UW Medicine
@@@ Rebecca Denney, PA-C – UW Medicine ### 1417846###Speaker###Teaching Associate/Advanced Practice Practitioner###UW Medicine###Speaker: – UW Medicine
@@@ Jennifer E. Jacky, ARNP, AOCNP – University of Washington/ Seattle Cancer Care Alliance ### 186953###Speaker###Nurse Practitioner/Teaching Associate###University of Washington/ Seattle Cancer Care Alliance###Speaker: – University of Washington/ Seattle Cancer Care Alliance
10:00 AM – 7:30 PM EDT
Industry Encore Posters
10:00 AM – 7:30 PM EDT
Industry Encore PostersPosters
11:15 AM – 12:00 PM EDT
Combining the HER2+ Breast Cancer Antibodies You Know in One Faster Mode of Administration - Genentech
11:15 AM – 12:00 PM EDT
Combining the HER2+ Breast Cancer Antibodies You Know in One Faster Mode of Administration - GenentechProduct Theater
12:15 PM – 1:00 PM EDT
Identifying the Leader in You
12:15 PM – 1:00 PM EDT
Identifying the Leader in YouSpeaker: – City of Hope
Speaker: – Texas Oncology
CE Session
Elisabeth King, RN, FNP, AOCNP, AGN – City of Hope ### 1444092###Speaker###Executive Director of Genomics and Precision Medicine ###City of Hope###Speaker: – City of Hope
@@@ Sara Toth, RN, APRN, FNP-C, AOCNP, AGN-BC – Texas Oncology ### 885905###Speaker###Director, APP Services###Texas Oncology###Speaker: – Texas Oncology
1:15 PM – 2:00 PM EDT
Molecular Testing for Hematologic Malignancies
1:15 PM – 2:00 PM EDT
Molecular Testing for Hematologic MalignanciesSpeaker: – University of California, San Francisco
CE Session
Laura J. Zitella, MS, RN, ACNP-BC, AOCN® – University of California, San Francisco ### 885844###Speaker###Nurse Practitioner/Associate Clinical Professor###University of California, San Francisco###Speaker: – University of California, San Francisco
2:15 PM – 3:00 PM EDT
A Treatment Option for the Management of Certain Patients with First-Line Non-Small Cell Lung Cancer - Bristol Myers Squibb
2:15 PM – 3:00 PM EDT
A Treatment Option for the Management of Certain Patients with First-Line Non-Small Cell Lung Cancer - Bristol Myers SquibbProduct Theater
3:15 PM – 4:15 PM EDT
Lung Cancer Biomarker Speak: Teach Me the Language
3:15 PM – 4:15 PM EDT
Lung Cancer Biomarker Speak: Teach Me the LanguageSpeaker: – Abramson Cancer Center, Hospital of the University of Pennsylvania
Speaker: – University of Pennsylvania
CE Session
Beth Sandy, MSN, CRNP – Abramson Cancer Center, Hospital of the University of Pennsylvania ### 285303###Speaker###Nurse Practitioner Thoracic Oncology###Abramson Cancer Center, Hospital of the University of Pennsylvania###Speaker: – Abramson Cancer Center, Hospital of the University of Pennsylvania
@@@ Jennifer J.D. Morrissette, PhD, FACMG – University of Pennsylvania ### 1436096###Speaker######University of Pennsylvania###Speaker: – University of Pennsylvania
4:30 PM – 5:15 PM EDT
Treating Advanced Prostate Cancer - Astellas and Pfizer
4:30 PM – 5:15 PM EDT
Treating Advanced Prostate Cancer - Astellas and PfizerProduct Theater
5:30 PM – 6:30 PM EDT
Multidisciplinary Management of Resectable Early-Stage Non-Small Cell Lung Cancer
5:30 PM – 6:30 PM EDT
Multidisciplinary Management of Resectable Early-Stage Non-Small Cell Lung CancerSpeaker: – UW Medicine
Speaker: – UW Medicine
Speaker: – University of Washington/ Seattle Cancer Care Alliance
CE Session
Repeat Session
Kristin DeGroot, PA-C – UW Medicine ### 1417845###Speaker###Physician Assistant/Teaching Associate###UW Medicine###Speaker: – UW Medicine
@@@ Rebecca Denney, PA-C – UW Medicine ### 1417846###Speaker###Teaching Associate/Advanced Practice Practitioner###UW Medicine###Speaker: – UW Medicine
@@@ Jennifer E. Jacky, ARNP, AOCNP – University of Washington/ Seattle Cancer Care Alliance ### 186953###Speaker###Nurse Practitioner/Teaching Associate###University of Washington/ Seattle Cancer Care Alliance###Speaker: – University of Washington/ Seattle Cancer Care Alliance
6:45 PM – 7:30 PM EDT
Identifying the Leader in You
6:45 PM – 7:30 PM EDT
Identifying the Leader in YouSpeaker: – City of Hope
Speaker: – Texas Oncology
CE Session
Repeat Session
Elisabeth King, RN, FNP, AOCNP, AGN – City of Hope ### 1444092###Speaker###Executive Director of Genomics and Precision Medicine ###City of Hope###Speaker: – City of Hope
@@@ Sara Toth, RN, APRN, FNP-C, AOCNP, AGN-BC – Texas Oncology ### 885905###Speaker###Director, APP Services###Texas Oncology###Speaker: – Texas Oncology
7:45 PM – 9:00 PM EDT
Independent Satellite Symposium: Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen Therapy
7:45 PM – 9:00 PM EDT
Independent Satellite Symposium: Navigating the Evolving Treatment Landscape in Prostate Cancer: A Focus on Novel Anti-androgen TherapySpeaker: – Robert H Lurie Comprehensive Cancer Center
Northwestern Medicine
Chicago, Illinois
Speaker: – Dana-Farber Cancer Institute
Boston, Massachusetts
Separate Registration
CE Session
Repeat Session
1.25 credits/contact hours
Brenda Martone, MSN, ANP-BC, AOCNP – Robert H Lurie Comprehensive Cancer Center
Northwestern Medicine
Chicago, Illinois ### 1458797###Speaker###Nurse Practitioner###Robert H Lurie Comprehensive Cancer Center
Northwestern Medicine
Chicago, Illinois###Speaker: – Robert H Lurie Comprehensive Cancer Center
Northwestern Medicine
Chicago, Illinois
@@@ Alicia K. Morgans, MD, MPH – Dana-Farber Cancer Institute
Boston, Massachusetts ### 1458798###Speaker###Faculty in Medicine
Harvard Medical School
Genitourinary Medical Oncologist
Medical Director, Survivorship Program###Dana-Farber Cancer Institute
Boston, Massachusetts###Speaker: – Dana-Farber Cancer Institute
Boston, Massachusetts
- Saturday, October 16, 2021
10:00 AM – 11:00 AM EDT
An AP Perspective on Infusion Reactions in the Era of Immunotherapy
10:00 AM – 11:00 AM EDT
An AP Perspective on Infusion Reactions in the Era of ImmunotherapySpeaker: – Dignity Health Cancer Institute
CE Session
Carrie J. Peterson, DNP, RN, AGNP-C – Dignity Health Cancer Institute ### 861289###Speaker###Nurse Practitioner###Dignity Health Cancer Institute###Speaker: – Dignity Health Cancer Institute
10:00 AM – 8:30 PM EDT
Industry Encore Posters
10:00 AM – 8:30 PM EDT
Industry Encore PostersPosters
11:15 AM – 12:00 PM EDT
Sarclisa + KD: An Anti-CD38 Combination for the Treatment of Multiple Myeloma Patients as Early as First Relapse - Sanofi Genzyme
11:15 AM – 12:00 PM EDT
Sarclisa + KD: An Anti-CD38 Combination for the Treatment of Multiple Myeloma Patients as Early as First Relapse - Sanofi GenzymeProduct Theater
12:00 PM – 1:00 PM EDT
Conversation Circles: Emotional Intelligence: An AP Growth Tool
12:00 PM – 1:00 PM EDT
Conversation Circles: Emotional Intelligence: An AP Growth ToolFacilitator: – McKesson Specialty Health / The US Oncology Network
Interactive Breakout
Networking
Jason Astrin, DMSc, MBA, PA-C, DFAAPA – McKesson Specialty Health / The US Oncology Network ### 270130###Facilitator###Director, Advanced Practice Provider Services###McKesson Specialty Health / The US Oncology Network###Facilitator: – McKesson Specialty Health / The US Oncology Network
12:00 PM – 1:00 PM EDT
Conversation Circles: Professional Bullying
12:00 PM – 1:00 PM EDT
Conversation Circles: Professional BullyingFacilitator: – Ballad Health Cancer Care
Interactive Breakout
Networking
Kelley D. Mayden, MSN,APRN-BC,AOCNP – Ballad Health Cancer Care ### 161957###Facilitator###Oncology Advanced Practice Provider ###Ballad Health Cancer Care###Facilitator: – Ballad Health Cancer Care
1:15 PM – 2:00 PM EDT
Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With Acute Myeloid Leukemia
1:15 PM – 2:00 PM EDT
Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With Acute Myeloid LeukemiaSpeaker: – The University of North Carolina at Chapel Hill
Speaker: – University of North Carolina Medical Center
CE Session
Ashley Leak Bryant, PhD, RN, OCN, FAAN – The University of North Carolina at Chapel Hill ### 1398778###Speaker###Associate Professor, School of Nursing ###The University of North Carolina at Chapel Hill###Speaker: – The University of North Carolina at Chapel Hill
@@@ Kaitlyn Buhlinger, PharmD, BCOP, CPP – University of North Carolina Medical Center ### 1398779###Speaker###Leukemia Clinical Pharmacist###University of North Carolina Medical Center###Speaker: – University of North Carolina Medical Center
2:00 PM – 2:30 PM EDT
Moderated Clinical Posters
2:00 PM – 2:30 PM EDT
Moderated Clinical PostersNetworking
Posters
2:30 PM – 3:15 PM EDT
The Advanced Practice Role in Clinical Trials: Past, Present, and Future
2:30 PM – 3:15 PM EDT
The Advanced Practice Role in Clinical Trials: Past, Present, and FutureSpeaker: – Winship Cancer Institute of Emory University
CE Session
Colleen Lewis, MSN, ANP-BC, AOCNP – Winship Cancer Institute of Emory University ### 761835###Speaker###Director of Clinical Operations/Lead APP, Phase I Clinical Trial Program###Winship Cancer Institute of Emory University###Speaker: – Winship Cancer Institute of Emory University
3:30 PM – 4:15 PM EDT
Advances in targeted therapy for CLL: Efficacy and Practical Management of BCL-2 inhibitors - AbbVie Medical Affairs
3:30 PM – 4:15 PM EDT
Advances in targeted therapy for CLL: Efficacy and Practical Management of BCL-2 inhibitors - AbbVie Medical AffairsProduct Theater
4:30 PM – 5:15 PM EDT
New Drug Updates: Investigational Therapeutics in the Pipeline
4:30 PM – 5:15 PM EDT
New Drug Updates: Investigational Therapeutics in the PipelineSpeaker: – Levine Cancer Institute, Atrium Health
CE Session
Donald C. Moore, PharmD, BCPS, BCOP, DPLA – Levine Cancer Institute, Atrium Health ### 1394202###Speaker###Pharmacist Clinical Coordinator - Hematology/Oncology###Levine Cancer Institute, Atrium Health###Speaker: – Levine Cancer Institute, Atrium Health
5:30 PM – 6:15 PM EDT
In Adult and Pediatric Patients 12 Years and Older with Chronic GVHD, Intervene with Jakafi® (ruxolitinib) At the First Sign of Initial Systemic Treatment Failure - Incyte Corporation
5:30 PM – 6:15 PM EDT
In Adult and Pediatric Patients 12 Years and Older with Chronic GVHD, Intervene with Jakafi® (ruxolitinib) At the First Sign of Initial Systemic Treatment Failure - Incyte CorporationProduct Theater
6:30 PM – 7:30 PM EDT
An AP Perspective on Infusion Reactions in the Era of Immunotherapy
6:30 PM – 7:30 PM EDT
An AP Perspective on Infusion Reactions in the Era of ImmunotherapySpeaker: – Dignity Health Cancer Institute
CE Session
Repeat Session
Carrie J. Peterson, DNP, RN, AGNP-C – Dignity Health Cancer Institute ### 861289###Speaker###Nurse Practitioner###Dignity Health Cancer Institute###Speaker: – Dignity Health Cancer Institute
7:45 PM – 8:30 PM EDT
Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With Acute Myeloid Leukemia
7:45 PM – 8:30 PM EDT
Role of the Advanced Practitioner in the Management of Oral Chemotherapy for Adults With Acute Myeloid LeukemiaSpeaker: – The University of North Carolina at Chapel Hill
Speaker: – University of North Carolina Medical Center
CE Session
Repeat Session
Ashley Leak Bryant, PhD, RN, OCN, FAAN – The University of North Carolina at Chapel Hill ### 1398778###Speaker###Associate Professor, School of Nursing ###The University of North Carolina at Chapel Hill###Speaker: – The University of North Carolina at Chapel Hill
@@@ Kaitlyn Buhlinger, PharmD, BCOP, CPP – University of North Carolina Medical Center ### 1398779###Speaker###Leukemia Clinical Pharmacist###University of North Carolina Medical Center###Speaker: – University of North Carolina Medical Center
- Sunday, October 17, 2021
8:30 AM – 9:45 AM EDT
Independent Satellite Symposium: Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies
8:30 AM – 9:45 AM EDT
Independent Satellite Symposium: Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized TherapiesSpeaker: – Sarah Cannon Research Institute
Nashville, Tennessee
Speaker: – University of Tennessee Health Science Center
Nashville, Tennessee
Separate Registration
CE Session
1.25 credits/contact hours
Melissa Rikal, MSN, FNP-BC – Sarah Cannon Research Institute
Nashville, Tennessee ### 1458799###Speaker###Nurse Practitioner
Tennessee Oncology
Oncology/Drug Development Unit###Sarah Cannon Research Institute
Nashville, Tennessee###Speaker: – Sarah Cannon Research Institute
Nashville, Tennessee
@@@ Lee Schwartzberg, MD, FACP – University of Tennessee Health Science Center
Nashville, Tennessee ### 1458800###Speaker###Medical Director, West Cancer Center
Chief Medical Officer, OneOncology
Professor of Medicine###University of Tennessee Health Science Center
Nashville, Tennessee###Speaker: – University of Tennessee Health Science Center
Nashville, Tennessee
10:00 AM – 11:00 AM EDT
Oncology Urgent Care Clinics: Understanding Utilization and Best Practices
10:00 AM – 11:00 AM EDT
Oncology Urgent Care Clinics: Understanding Utilization and Best PracticesSpeaker: – Memorial Sloan Kettering Cancer Center
Speaker: – Memorial Sloan Kettering Cancer Center
CE Session
Cara Fleming, AGPCNP-BC, AOCNP – Memorial Sloan Kettering Cancer Center ### 1394203###Speaker###Nurse Practitioner###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
@@@ Deirdre Kelly, ACNP – Memorial Sloan Kettering Cancer Center ### 1394204###Speaker###Nurse Practitioner###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
10:00 AM – 7:45 PM EDT
Industry Encore Posters
10:00 AM – 7:45 PM EDT
Industry Encore PostersPosters
11:15 AM – 12:00 PM EDT
Educate Your Patients on IMBRUVICA® (ibrutinib) Treatment - Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.
11:15 AM – 12:00 PM EDT
Educate Your Patients on IMBRUVICA® (ibrutinib) Treatment - Pharmacyclics LLC, an AbbVie Company and Janssen Biotech, Inc.Product Theater
12:15 PM – 1:15 PM EDT
Race, Social Determinants of Health, and Cancer: How Can APs Address and Improve Patient Outcomes?
12:15 PM – 1:15 PM EDT
Race, Social Determinants of Health, and Cancer: How Can APs Address and Improve Patient Outcomes?Speaker: – Thomas Jefferson University Hospital
Speaker: – Memorial Sloan Kettering Cancer Center
CE Session
Rose DiMarco, PharmD, BCPS, BCOP – Thomas Jefferson University Hospital ### 1417520###Speaker###Advanced Clinical Pharmacist - Oncology###Thomas Jefferson University Hospital###Speaker: – Thomas Jefferson University Hospital
@@@ Lisania I. Milli, MSN, WHNP-BC – Memorial Sloan Kettering Cancer Center ### 1417518###Speaker###APP Manager/Nurse Practitioner in GYN Oncology###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
1:30 PM – 2:15 PM EDT
The Critical Role of Nutrition and Exercise Optimization in the Patient With Cancer
1:30 PM – 2:15 PM EDT
The Critical Role of Nutrition and Exercise Optimization in the Patient With CancerSpeaker: – Duke University School of Medicine
CE Session
Paul Wischmeyer, MD, EDIC, FASPEN, FCCM – Duke University School of Medicine ### 1428952###Speaker###Professor of Anesthesiology and Surgery (with Tenure)###Duke University School of Medicine###Speaker: – Duke University School of Medicine
2:30 PM – 3:15 PM EDT
Raising Awareness: What the Patient Care Team Should Know About Metastatic Non-Small Cell Lung Cancer (mNSCLC) With EGFR Exon 20 Insertion Mutations - Janssen
2:30 PM – 3:15 PM EDT
Raising Awareness: What the Patient Care Team Should Know About Metastatic Non-Small Cell Lung Cancer (mNSCLC) With EGFR Exon 20 Insertion Mutations - JanssenProduct Theater
3:30 PM – 4:15 PM EDT
Multidisciplinary Tumor Boards and Guiding Patient Care: The AP Role
3:30 PM – 4:15 PM EDT
Multidisciplinary Tumor Boards and Guiding Patient Care: The AP RoleSpeaker: – Kaiser Permanente San Francisco
Speaker: – Kaiser Permanante
CE Session
Joan Y. Okasako, BSN, FNP, MSN, AOCNP – Kaiser Permanente San Francisco ### 1398041###Speaker###Nurse Practitioner ###Kaiser Permanente San Francisco ###Speaker: – Kaiser Permanente San Francisco
@@@ Carolyn Bernstein, ANP – Kaiser Permanante ### 1398044###Speaker###Oncology Nurse Practitioner###Kaiser Permanante###Speaker: – Kaiser Permanante
4:30 PM – 5:15 PM EDT
Monjuvi (Tafasitamab-Cxix) For Use As Second-Line Therapy In Adult Patients With R/R DLBCL, In Combination With Lenalidomide - Incyte Corporation and MorphoSys US Inc.
4:30 PM – 5:15 PM EDT
Monjuvi (Tafasitamab-Cxix) For Use As Second-Line Therapy In Adult Patients With R/R DLBCL, In Combination With Lenalidomide - Incyte Corporation and MorphoSys US Inc.Product Theater
5:30 PM – 6:30 PM EDT
Oncology Urgent Care Clinics: Understanding Utilization and Best Practices
5:30 PM – 6:30 PM EDT
Oncology Urgent Care Clinics: Understanding Utilization and Best PracticesSpeaker: – Memorial Sloan Kettering Cancer Center
Speaker: – Memorial Sloan Kettering Cancer Center
CE Session
Repeat Session
Cara Fleming, AGPCNP-BC, AOCNP – Memorial Sloan Kettering Cancer Center ### 1394203###Speaker###Nurse Practitioner###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
@@@ Deirdre Kelly, ACNP – Memorial Sloan Kettering Cancer Center ### 1394204###Speaker###Nurse Practitioner###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
6:45 PM – 7:45 PM EDT
Race, Social Determinants of Health, and Cancer: How Can APs Address and Improve Patient Outcomes?
6:45 PM – 7:45 PM EDT
Race, Social Determinants of Health, and Cancer: How Can APs Address and Improve Patient Outcomes?Speaker: – Thomas Jefferson University Hospital
Speaker: – Memorial Sloan Kettering Cancer Center
CE Session
Repeat Session
Rose DiMarco, PharmD, BCPS, BCOP – Thomas Jefferson University Hospital ### 1417520###Speaker###Advanced Clinical Pharmacist - Oncology###Thomas Jefferson University Hospital###Speaker: – Thomas Jefferson University Hospital
@@@ Lisania I. Milli, MSN, WHNP-BC – Memorial Sloan Kettering Cancer Center ### 1417518###Speaker###APP Manager/Nurse Practitioner in GYN Oncology###Memorial Sloan Kettering Cancer Center###Speaker: – Memorial Sloan Kettering Cancer Center
8:00 PM – 9:15 PM EDT
Independent Satellite Symposium: Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized Therapies
8:00 PM – 9:15 PM EDT
Independent Satellite Symposium: Metastatic HER2-Positive Breast Cancer: Newer and Emerging Treatment Considerations and Personalized TherapiesSpeaker: – Sarah Cannon Research Institute
Nashville, Tennessee
Speaker: – University of Tennessee Health Science Center
Nashville, Tennessee
Separate Registration
CE Session
Repeat Session
1.25 credits/contact hours
Melissa Rikal, MSN, FNP-BC – Sarah Cannon Research Institute
Nashville, Tennessee ### 1458799###Speaker###Nurse Practitioner
Tennessee Oncology
Oncology/Drug Development Unit###Sarah Cannon Research Institute
Nashville, Tennessee###Speaker: – Sarah Cannon Research Institute
Nashville, Tennessee
@@@ Lee Schwartzberg, MD, FACP – University of Tennessee Health Science Center
Nashville, Tennessee ### 1458800###Speaker###Medical Director, West Cancer Center
Chief Medical Officer, OneOncology
Professor of Medicine###University of Tennessee Health Science Center
Nashville, Tennessee###Speaker: – University of Tennessee Health Science Center
Nashville, Tennessee
